RILP Induces Cholesterol Accumulation in Lysosomes by Inhibiting Endoplasmic Reticulum–Endolysosome Interactions
Cells · 2024
DOI: 10.3390/cells13161313 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Yang Han und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Resear…. Hauptthemen laut MEDLINE: Lysosomes, Cholesterol, Endoplasmic Reticulum, Endosomes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Endoplasmic reticulum (ER)–endolysosome interactions regulate cholesterol exchange between the ER and the endolysosome. ER–endolysosome membrane contact sites mediate the ER–endolysosome interaction. VAP-ORP1L (vesicle-associated membrane protein-associated protein- OSBP-related protein 1L) interaction forms the major contact site between the ER and the lysosome, which is regulated by Rab7. RILP (Rab7-interacting lysosomal protein) is the downstream effector of Rab7, but its role in the organelle interaction between the ER and the lysosome is not clear. In this study, we found RILP interacts with ORP1L to competitively inhibit the formation of the VAP–ORP1L contact site. Immunofluorescence microscopy revealed that RILP induces late endosome/lysosome clustering, which reduces the contact of endolysosomes with the ER, interfering with the ER–endolysosome interaction. Further examination demonstrated that over-expression of RILP results in the accumulation of cholesterol in the clustered endolysosomes, which triggers cellular autophagy depending on RILP. Our results suggest that RILP interferes with the ER–endolysosome interaction to inhibit cholesterol flow from the endolysosome to the ER, which feedbacks to trigger autophagy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China.
- Institute of Molecular and Cell Biology, A*STAR (Agency of Science, Technology and Research), Singapore 138673, Singapore.
ORCID-Profile: Tuanlao Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Han, Y., Liu, X., Xu, L., Wei, Z., Gu, Y., Ren, Y., Hua, W., Zhang, Y., Liu, X., Jiang, C., Zhuang, R., Hong, W., & Wang, T. (2024). RILP Induces Cholesterol Accumulation in Lysosomes by Inhibiting Endoplasmic Reticulum–Endolysosome Interactions. Cells. https://doi.org/10.3390/cells13161313
Vancouver
Han Y, Liu X, Xu L, Wei Z, Gu Y, Ren Y, et al. RILP Induces Cholesterol Accumulation in Lysosomes by Inhibiting Endoplasmic Reticulum–Endolysosome Interactions. Cells. 2024. doi:10.3390/cells13161313
BibTeX
@article{Han2024,
author = {Han, Yang and Liu, Xiaoqing and Xu, Liju and Wei, Ziheng and Gu, Yueting and Ren, Yandan and Hua, Wenyi and Zhang, Yongtao and Liu, Xiaoxi and Jiang, Cong and Zhuang, Ruijuan and Hong, Wanjin and Wang, Tuanlao},
title = {RILP Induces Cholesterol Accumulation in Lysosomes by Inhibiting Endoplasmic Reticulum–Endolysosome Interactions},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13161313}
}
EUVIMED